RERE

protein-coding

arginine-glutamic acid dipeptide repeats, the group of Myb/SANT domain containing|Atrophins|GATA zinc finger domain containing

Gene summary

This gene encodes a member of the atrophin family of arginine-glutamic acid (RE) dipeptide repeat-containing proteins. The encoded protein co-localizes with a transcription factor in the nucleus, and its overexpression triggers apoptosis. A similar protein in mouse associates with histone deacetylase and is thought to function as a transcriptional co-repressor during embryonic development. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Previous symbols:
  • ATN1L

MANE transcript

NM_001042681.2

Inheritance

AD

ClinVar variants

P:78U:609B:365

Top phenotype

Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart

gnomAD constraint

pLI —, LoF o/e 0.05

Max pathogenic AF

—

Genomic locus

chr1:8,352,397-8,848,921

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~496.5 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

neurodevelopmental disorder with or without anomalies of the brain, eye, or heartSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014857

Submitter: PanelApp Australia

neurodevelopmental disorder with or without anomalies of the brain, eye, or heartDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0014857

Submitter: G2P

neurodevelopmental disorder with or without anomalies of the brain, eye, or heartSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014857

Submitter: Ambry Genetics

neurodevelopmental disorder with or without anomalies of the brain, eye, or heartSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014857

Submitter: Labcorp Genetics (formerly Invitae)

complex neurodevelopmental disorder with or without congenital anomaliesDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0100465

Submitter: ClinGen

*RERE* was first reported in relation to autosomal dominant complex neurodevelopmental disorder with or without congenital anomalies in 2016 (Fregeau et al., PMID: 27087320). *RERE*-related complex neurodevelopmental disorder with or without congenital anomalies most often presents with developmental delay, intellectual disability, and autism. Additional syndromic abnormalities, which are not always present, most commonly involve the eyes, heart, and genitourinary system (i.e. coloboma, optic atrophy/hypoplasia, ventricular septal defect, gastroesophageal reflux disease, and hypotonia). Nine variants (missense, nonsense, and frameshift) that have been reported in 9 probands in 3 publications (PMIDs: 27087320, 29330883, 31452935) are included in this curation. The mechanism of pathogenicity is believed to be loss of function. This gene-disease relationship is also supported by a mouse model recapitulating the human phenotype (postnatal growth deficiency, brain hypoplasia, decreased numbers of hippocampal neurons, hearing loss, cardiovascular malformations, ventriculomegaly, incomplete closure of the optic fissure, and renal agenesis) and biochemical function demonstrating *RERE*’s role in development through retinoic acid signaling (PMIDs: 20164929, 23451234). In summary, there is definitive evidence supporting the relationship between *RERE* and autosomal dominant complex neurodevelopmental disorder with or without congenital anomalies. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on March 21, 2023 (SOP Version 9).

neurodevelopmental disorder with or without anomalies of the brain, eye, or heartSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0014857

Submitter: Orphanet

Clinical Genomic Database (CGD)

Neurodevelopmental disorder with or without anomalies of the brain, eye, or heartAD

Manifestation: Cardiovascular; Craniofacial; Genitourinary; Neurologic; Ophthalmologic

Intervention: Cardiovascular

Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early management

Refs: 27087320Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to RERE variants in ClinVar

15 Conditions Cataloged
not providedTotal: 782
Inborn genetic diseasesTotal: 302
Neurodevelopmental disorder with or without anomalies of the brain, eye, or heartTotal: 190
not specifiedTotal: 120
RERE-related disorderTotal: 83
See casesTotal: 7
CHARGE syndromeTotal: 1
Neurodevelopmental disorderTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001042681.2. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
12
clinvar
196
clinvar
27
clinvar
236
missense
6
clinvar
18
clinvar
582
clinvar
130
clinvar
12
clinvar
748
nonsense
4
clinvar
10
clinvar
5
clinvar
19
start loss
0
frameshift
11
clinvar
21
clinvar
4
clinvar
36
splice donor/acceptor (+/-2bp)
7
clinvar
6
clinvar
13
Total2157609326391052

Highest pathogenic variant AF is 0.000008754804

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 29 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001042681.2RefSeqNP_001036146.122MANE Select
ENST00000400908.7EnsemblENSP00000383700.222MANE Select
NM_001042682.2RefSeqNP_001036147.19Standard
NM_012102.4RefSeqNP_036234.322Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
rereaDanio rerio

Structure: hair cell

Quality: quality

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • chromatin remodeling
  • regulation of transcription by RNA polymerase II
  • NLS-bearing protein import into nucleus
  • cerebellar Purkinje cell layer maturation
  • cerebellar granule cell precursor proliferation

Molecular Function

  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • RNA polymerase II transcription factor binding
  • DNA binding
  • chromatin binding
  • transcription coactivator activity

Cellular Component

  • histone deacetylase complex
  • nucleus

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000337907
Coding exons
22
Length
465246
Individuals with no LoFs
125713
Homozygous LoFs
0
Heterozygous LoFs
34
Defined
125747
p
0.000135
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.037379090.8100.000058910049
Missense (PolyPhen)187316.280.591243317
Synonymous-2.834533831.180.00002693205
Loss of Function7.11364.70.04630.00000377718

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000130.000062rare
Latino/Admixed American0.000120.000058rare
Ashkenazi Jewish0.000210.00020rare
East Asian0.000110.000054rare
Finnish00.0absent
European (Non-Finnish)0.000380.00021rare
South Asian0.000250.00013rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Plays a role as a transcriptional repressor during development. May play a role in the control of cell survival. Overexpression of RERE recruits BAX to the nucleus particularly to POD and triggers caspase-3 activation, leading to cell death. {ECO:0000269|PubMed:11331249}.;
Disease
DISEASE: Note=A chromosomal aberration involving RERE is found in the neuroblastoma cell line NGP. Translocation t(1;15)(p36.2;q24).; DISEASE: Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart (NEDBEH) [MIM:616975]: An autosomal dominant syndrome characterized by developmental delay, intellectual disability, brain anomalies, and neurological abnormalities including seizures, hypotonia, and behavioral problems such as autism spectrum disorders. Brain anomalies include abnormalities and/or thinning of the corpus callosum, diminished white matter volume, abnormal cerebellar vermis, and ventriculomegaly. Congenital defects of the eye, heart and genitourinary system are present in half of the patients. {ECO:0000269|PubMed:27087320}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.139

Intolerance Scores

LoFtool
0.0674
RVIS EVS
-2.63
RVIS percentile EVS
0.78

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.717

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.